Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elise R A Pennings

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|February 12, 2026
Navigating Ethical Challenges in CAR-T TreatmentElise R A Pennings, Anne M Spanjaart, Anne Ruth Schaaphok, et al.
Blood Cancer Journal|January 4, 2024
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the NetherlandsElise R A Pennings, Müjde Durmaz, Otto Visser, et al.
Hematological Oncology|June 29, 2023
Cellular therapy in lymphomaAnna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Cancers|November 25, 2023
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related ToxicitiesJanneke W de Boer, Kylie Keijzer, Elise R A Pennings, et al.
Hemasphere|March 9, 2026
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignanciesElise R A Pennings, Frederick W Thielen, Florence Broussais, et al.
Blood Advances|August 28, 2023
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapyJanneke W de Boer, Elise R A Pennings, Ankie Kleinjan, et al.
JCO Oncology Practice|December 12, 2022
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy ToxicitiesAnne M Spanjaart, Elise R A Pennings, Milan Kos, et al.
Cancers|September 9, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The NetherlandsAnne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, et al.
Blood Advances|September 24, 2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in EuropeElise R A Pennings, Anne M Spanjaart, Frederick W Thielen, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
HEC Forum : an Interdisciplinary Journal on Hospitals' Ethical and Legal Issues|February 12, 2026
Navigating Ethical Challenges in CAR-T TreatmentElise R A Pennings, Anne M Spanjaart, Anne Ruth Schaaphok, et al.
Blood Cancer Journal|January 4, 2024
Treatment and outcomes for patients with relapsed or refractory diffuse large B-cell lymphoma: a contemporary, nationwide, population-based study in the NetherlandsElise R A Pennings, Müjde Durmaz, Otto Visser, et al.
Hematological Oncology|June 29, 2023
Cellular therapy in lymphomaAnna Sureda, Pieternella J Lugtenburg, Marie José Kersten, et al.
Cancers|November 25, 2023
Population-Based External Validation of the EASIX Scores to Predict CAR T-Cell-Related ToxicitiesJanneke W de Boer, Kylie Keijzer, Elise R A Pennings, et al.
Hemasphere|March 9, 2026
The European CAR-T map-Current status and future directions to improve access to CAR T-cell therapy for hematologic malignanciesElise R A Pennings, Frederick W Thielen, Florence Broussais, et al.
Blood Advances|August 28, 2023
Inflammatory reactions mimic residual or recurrent lymphoma on [18F]FDG-PET/CT after CD19-directed CAR T-cell therapyJanneke W de Boer, Elise R A Pennings, Ankie Kleinjan, et al.
JCO Oncology Practice|December 12, 2022
Development of a Core Set of Patient- and Caregiver-Reported Signs and Symptoms to Facilitate Early Recognition of Acute Chimeric Antigen Receptor T-Cell Therapy ToxicitiesAnne M Spanjaart, Elise R A Pennings, Milan Kos, et al.
Cancers|September 9, 2023
The Dutch CAR-T Tumorboard Experience: Population-Based Real-World Data on Patients with Relapsed or Refractory Large B-Cell Lymphoma Referred for CD19-Directed CAR T-Cell Therapy in The NetherlandsAnne M Spanjaart, Elise R A Pennings, Pim G N J Mutsaers, et al.
Blood Advances|September 24, 2025
Patient-reported outcomes in patients with hematologic malignancies treated with CAR T-cell therapy in EuropeElise R A Pennings, Anne M Spanjaart, Frederick W Thielen, et al.
Pageof 1